Avivia
Harro Antheunis is a highly skilled professional in the field of chemical engineering and polymer chemistry, currently serving as a Senior Product Development Engineer and Business Development Manager at Avivia since March 2023. Prior to Avivia, Harro held the position of Product Implementation Manager at Sponsh, advising on the production of innovative products, including a device for water harvesting from air. Harro founded PMME, specializing in guiding products from concept to production, and operated Antheunis Technologie, focusing on high-quality polymer development. Earlier roles include Research Fellow at PTG Eindhoven, Teacher of Polymer and Organic Chemistry at HLO Nijmegen, Process Engineer at Organon, and Researcher at Synthon, coupled with extensive education in chemical engineering and polymer science from esteemed institutions.
This person is not in the org chart
This person is not in any teams
Avivia
Avivia is a Dutch independent pharmaceutical R&D service organization and your partner in drug (re)formulation, repurposing and repositioning. Avivia is specialized in medicinal product development. From product evaluation to comprehensive formulation and analytical development, excipient characterisation, defomulation, dissolution test development, stability studies, IMPD production, CMO selection and transfer. Our expertise and capabilities are centered around the development of value-added generic drugs, life cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). Avivia has four complementary pharmaceutical R&D speciality service platforms: - Pharmaceutical R&D Services - Analytical R&D Services - Dissolution Lab Services - Excipia ™ Avivia for all Big Pharma, speciality pharma, drug development firms, generic drug companies, universities, law firms, excipient manufacturers and even venture capital firms… our customer base is very broad and diverse. IP Protection, creation and evasion Be it the protection or creation of new formulation patents for originator products or the evasion of established formulation patents for generic drug development, we are constantly seeking new IP opportunities to maximize product value. Network to accelerate Avivia has access to a great team of pharmaceutical and analytical development professionals as well as to state-of-the-art laboratory infrastructure and equipment. We have also developed a large network or preferred partners in other fields such as pre-clinical development, GMP manufacturing and regulatory affairs. Excipia. Excipia is our excipient knowledge platform focused on excipient related troubleshooting, characterization and reversed engineering, see our dedicated website https://www.excipia.eu. If you are interested to learn more about Avivia, don’t hesitate to contact us and we would be happy to help you accelerating your development programs!